Apparent transverse relaxation (R2∗) on MRI as a method to differentiate treatment effect (pseudoprogression) versus progressive disease in chemoradiation for malignant glioma.

about

Apparent transverse relaxation (R2∗) on MRI as a method to differentiate treatment effect (pseudoprogression) versus progressive disease in chemoradiation for malignant glioma.

Item

http://www.wikidata.org/entity/Q47385832

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Apparent transverse relaxation ...... adiation for malignant glioma.

@en

Apparent transverse relaxation

@nl

type

Item

label

Apparent transverse relaxation ...... adiation for malignant glioma.

@en

Apparent transverse relaxation

@nl

prefLabel

Apparent transverse relaxation ...... adiation for malignant glioma.

@en

Apparent transverse relaxation

@nl

P1476

Apparent transverse relaxation ...... adiation for malignant glioma.

@en

P2093

David Macdonald

http://www.w3.org/2001/XMLSchema#string

Glenn S Bauman

http://www.w3.org/2001/XMLSchema#string

L Martyn Klassen

http://www.w3.org/2001/XMLSchema#string

Maria Macdonald

http://www.w3.org/2001/XMLSchema#string

P2860

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

Pseudoprogression in high-grade glioma.

Quantitative susceptibility mapping (QSM) of white matter multiple sclerosis lesions: Interpreting positive susceptibility and the presence of iron

Pitfalls in the neuroimaging of glioblastoma in the era of antiangiogenic and immuno/targeted therapy - detecting illusive disease, defining response.

Incidence of early pseudo-progression in a cohort of malignant glioma patients treated with chemoirradiation with temozolomide.

Comparison of dynamic susceptibility-weighted contrast-enhanced MR methods: recommendations for measuring relative cerebral blood volume in brain tumors

Evaluation of pseudoprogression in patients with glioblastoma multiforme using dynamic magnetic resonance imaging with ferumoxytol calls RANO criteria into question.

P31

scholarly article

P356

10.1111/1754-9485.12694

http://www.w3.org/2001/XMLSchema#string

P50

Ravi S. Menon

Jean-Guy Belliveau

P577

2017-11-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29193849

http://www.w3.org/2001/XMLSchema#string

P921

chemoradiotherapy